Correlation of HER2 expression and clinicopathological characteristics in patients with urothelial carcinoma in China

Correlation of HER2 expression and clinicopathological characteristics in patients with urothelial carcinoma in China

Background and purpose: Human epidermal growth factor receptor 2 (HER2) is closely associated with drug efficacy and prognosis in urothelial carcinoma (UC). HER2 is a significant biomarker and therapeutic target in various tumors. In recent years, anti-HER2 antibody-drug conjugates have shown signif...

Full description

Saved in:

Bibliographic Details
Main Author:	WANG Shanshan, YE Dingwei, YANG Li, CHENG Fan, YANG Tiejun, ZHANG Xiaoping, YU Zhixian, ZHANG Qingyun, YANG Yong
Format:	Article
Language:	English
Published:	Editorial Office of China Oncology 2024-11-01
Series:	Zhongguo aizheng zazhi
Subjects:	\|urothelial carcinoma\|human epidermal growth factor receptor 2\|clinicopathological characteristics\|china
Online Access:	http://www.china-oncology.com/fileup/1007-3639/PDF/1733904217468-1023638791.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Expression of PD-L1, AR, and P53 in urothelial carcinoma and their correlation with clinical prognosis
by: ZHOU Xiaodie, Qi Rongxin, WANG Xuan, YU Bo, WANG Jianjun, SHI Qunli, RAO Qiu, BAO Wei
Published: (2025-06-01)

Distribution and clinicopathological characteristics of G-CSF expression in tumor cells and stromal cells in upper tract urothelial carcinoma
by: Go Kobayashi, et al.
Published: (2024-12-01)

Enfortumab Vedotin–Induced Toxic Epidermal Necrolysis in Metastatic Urothelial Carcinoma Complicated by Severe Gastrointestinal Bleeding
by: Aika Matsuyama, et al.
Published: (2025-07-01)

Artificial Intelligence and Novel Technologies for the Diagnosis of Upper Tract Urothelial Carcinoma
by: Nikolaos Kostakopoulos, et al.
Published: (2025-05-01)

An Immunohistochemical Study in Urothelial Carcinoma of HER2/neu in Iraqi Patients
by: Athraa Falah Alshimerry
Published: (2025-01-01)

Therapeutic strategies for asymptomatic upper urinary tract urothelial carcinoma
by: Deng Lin, et al.
Published: (2022-12-01)

Clinical significance of HER2 in urothelial carcinoma and analysis of its correlation with glycolytic metabolic characteristics
by: Andong Guo, et al.
Published: (2024-12-01)

Genetic Alterations in Chromatin Regulatory Genes in Upper Tract Urothelial Carcinoma and Urothelial Bladder Cancer
by: Shuo Wang, et al.
Published: (2024-11-01)

The Evaluation of CD10 and HER2 Immunohistochemical Markers in Urothelial Carcinoma of Urinary Bladder
by: Khalid W. Abdulfattah Khattab, et al.
Published: (2024-12-01)

Immunohistochemical Expression of COX2 in Urothelial Carcinoma of the urinary bladder
by: Shayan Khattab Omer, et al.
Published: (2024-12-01)

Immunohistochemical expression of GATA3 in urothelial carcinoma of urinary bladder
by: Shadan Abdulkhaliq Jaf, et al.
Published: (2024-12-01)

Clinical Characteristics, Treatment Delivery, and Cisplatin Eligibility in Korean Patients Initially Diagnosed with Urothelial Carcinoma
by: Kwonoh Park, et al.
Published: (2021-07-01)

Prognostic and clinicopathological value of dbc1 expression in human cancers: a systematic review and meta-analysis
by: Haojia Wang, et al.
Published: (2025-07-01)

Immunohistochemical Expression of p53 in Epithelial Ovarian Carcinoma and Its Correlation with Clinicopathological Parameters
by: Farzana Sharmin, et al.

Prostate gland urothelial carcinoma: peculiarities of clinical course, patho- and morphogenesis
by: M. I. Servetnyk
Published: (2012-12-01)

Transformation from prostate adenocarcinoma to high-grade invasive urothelial carcinoma: A case report
by: Dihao Lv, et al.
Published: (2025-08-01)

Plasmacytoid urothelial carcinoma with duodenal metastasis—A rare tumor with unusual site of metastasis with grim outcome
by: Aparna Chenniappan, et al.
Published: (2023-01-01)

Immune checkpoint inhibitors in high‐grade upper tract urothelial carcinoma: Paradigm shift emphasizing organ preservation
by: Mahmoud Khalil, et al.
Published: (2024-05-01)

Analysis of the Clinicopathological Characteristics, Genetic Phenotypes, and Prognostics of Primary Pulmonary and Bronchial Adenoid Cystic Carcinoma
by: Zhengyang Hu, et al.
Published: (2025-01-01)

Sarcopenia in Urothelial Bladder Carcinoma: A Narrative Review
by: Constantin Radu Vrabie, et al.
Published: (2025-07-01)

GLPp16 gene amplification induces susceptibility to high-grade urothelial carcinoma
by: Yuxin Liu, et al.
Published: (2024-11-01)

Trends in the use and efficacy of adjuvant immunotherapy in muscle-invasive urothelial carcinoma
by: Shingo Hatakeyama, et al.
Published: (2025-07-01)

Artificial-Intelligence-Based Automatic Analysis of Urothelial Carcinomas – Our Experience
by: Sabina ZURAC, et al.
Published: (2025-05-01)

Bisulfite‐free PCDHGB7 methylation in urine enables early noninvasive detection of urothelial carcinoma
by: Zhicong Yang, et al.
Published: (2025-07-01)

A histopathological and epidemiological study of urothelial carcinoma at a tertiary care centre in Peshawar, Pakistan
by: Saria Saeed, et al.
Published: (2024-05-01)

Brain metastasis in a patient with metastatic urothelial carcinoma after 7 years of avelumab maintenance therapy: A case report
by: Kristoffer Ambeck Aagaard, et al.
Published: (2025-07-01)

[Cost Evaluation of First-Year Treatment for Locally Advanced or Metastatic Urothelial Carcinoma with Chemotherapy Plus Avelumab vs Chemotherapy Plus Best Supportive Care: A Cost of Care Model]
by: Daniela Paola Roggeri, et al.
Published: (2025-08-01)

Efficacy of modified enfortumab vedotin ineligible criteria (mEVITA) in advanced urothelial carcinoma
by: Takafumi Fukushima, et al.
Published: (2025-07-01)

Clinicopathological features and prognosis of mucinous breast carcinoma with a micropapillary structure
by: Beibei Yang, et al.
Published: (2024-12-01)

Rectal metastasis from bladder urothelial carcinoma: a case report
by: Yuki Ii, et al.
Published: (2021-04-01)

Utility of Urinary miRNA Biomarkers for Canine Urothelial Carcinoma Diagnostics
by: Alexandra Kehl, et al.
Published: (2025-06-01)

Clinicopathologic characteristics and prognostic factors of pure gastric neuroendocrine carcinoma patients undergoing radical surgery
by: Kai Zhou, et al.
Published: (2025-04-01)

Pediatric papillary urothelial neoplasm: 18-year single-center experience in diagnosis and treatment
by: Pei Liu, et al.
Published: (2025-06-01)

Association of HER2-low with clinicopathological features in patients with early invasive lobular breast cancer: an international multicentric study
by: Karen Van Baelen, et al.
Published: (2025-06-01)

Brazilian consensus in muscle-invasive and metastatic urothelial carcinoma
by: Andrey Soares, et al.
Published: (2020-01-01)

Pathological features and immunohistochemical characteristics of clear cell (glycogen-rich) urothelial carcinoma: a case report and systematic review of the literature
by: Weiming Wang, et al.
Published: (2025-02-01)

Review of recent molecular pathology of bladder urothelial carcinoma
by: Peng Su, et al.
Published: (2025-03-01)

Clinicopathological Characteristics and Survival Outcome among Patients with Renal Cell Carcinoma: A Northern Malaysian Experience
by: Yiie Huern Seo

Screening of methylation-related genes and construction of prognostic model in bladder urothelial carcinoma
by: LU Huiru, et al.
Published: (2025-03-01)

Validation of Cxbladder® Triage and Monitor as an Adjunct to Urothelial Carcinoma Diagnosis and Surveillance in a Single Centre
by: Magee D, et al.
Published: (2025-03-01)